Related Experiment Videos
Group B streptococcal infection in the perinatal period. An increasing problem in newborn care
Insights
Group B Streptococcus (GBS) infections in newborns are rising, presenting as early-onset sepsis or late-onset meningitis. Current prevention strategies for GBS disease are lacking.
Area of Science:
- Neonatal infections
- Bacterial pathogenesis
- Maternal-fetal health
Background:
- Group B streptococcal (GBS) infections pose a significant threat to newborn infants, with increasing incidence.
- GBS infections manifest in two distinct forms: early-onset disease (within 24 hours) and late-onset disease (after the first week).
- Early-onset GBS disease presents as severe sepsis with high mortality (40-70%), while late-onset disease, often meningitis, has lower mortality (20-30%) but a high rate of neurological sequelae.
Purpose of the Study:
- To highlight the growing problem of Group B Streptococcus infections in newborns.
- To describe the clinical presentations and outcomes of early- and late-onset GBS disease.
- To underscore the lack of effective preventive measures for GBS infections.
Main Methods:
- Review of clinical presentations and outcomes of GBS infections.
- Analysis of disease onset timing and associated mortality rates.
- Examination of transmission routes and maternal colonization prevalence.
Main Results:
- Early-onset GBS disease has a mortality rate of 40-70%.
- Late-onset GBS disease, primarily meningitis, has a mortality rate of 20-30% and frequently results in neurological damage.
- GBS is acquired during delivery from maternal vaginal colonization, affecting up to 25% of women in late pregnancy.
Conclusions:
- Group B streptococcal infections represent a critical and increasing challenge in neonatal care.
- The high mortality and morbidity associated with GBS necessitate urgent development of effective prevention programs.
- Understanding transmission dynamics is crucial for future intervention strategies.
Abstract:
Group B streptococcal infections in newborn infants are increasing in frequency. Infection takes two forms--early-onset, developing in the first 24 hours, and late-onset, developing after the first week. Early-onset disease, a fulminating septicaemia, has a mortality of 40-70%. Late-onset disease, usually meningitis, has a mortality of 20-30%, with a high incidence of neurological damage in survivors. Early-onset disease is acquired during delivery from organisms colonizing the vagina. Up to 25% of women are colonized in late pregnancy. So far, no effective programmes for prevention have been developed.